SEARCH

SEARCH BY CITATION

References

  • Ahlemeyer B. & Krieglstein J. (2000) Inhibition of glutathione depletion by retinoic acid and tocopherol protects cultured neurons from staurosporine-induced oxidative stress and apoptosis. Neurochem. Int. 36, 15.DOI: 10.1016/s0197-0186(99)00101-1
  • Alam Z. I., Daniel S. E., Lees A. J., Marsden D. C., Jenner P. & Halliwell B. (1997a) A generalized increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. J. Neurochem. 69, 13261329.
  • Alam Z. I., Jenner A., Daniel S. E., Lees A. J., Cairns N., Marsden C. D., Jenner P. & Halliwell B. (1997b) Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J. Neurochem. 69, 11961203.
  • Angulo A., Suto C. & Ghazal P. (1995) Retinoid activation of retinoic acid receptors but not of retinoid X receptors promotes cellular differentiation and replication of human cytomegalovirus in embryonal cells. J. Virol. 69, 38313837.
  • Beal M. F. (1997) Oxidative damage in neurodegenerative diseases. Neuroscience 3, 2127.
  • Bennett M. C., Bishop J. F., Leng Y., Chock P. B., Chase T. N. & Mouradian M. M. (1999) Degradation of α-synuclein by proteasome. J. Biol. Chem. 274, 3385533858.
  • Biedler J. L., Roffler-Tarlov S., Schner M. & Freeman L. S. (1978) Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res. 38, 37513757.
  • Bjorklund A., Rosenblad C., Winkler C. & Kirik D. (1997) Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease. Neurobiol. Dis. 4, 186200.DOI: 10.1006/nbdi.1997.0151
  • Chirico S. (1994) High-performance liquid chromatography-based thiobarbituric acid tests. Methods Enzymol. 233, 314318.
  • Cohen G., Farooqui R. & Kesler N. (1997) Parkinson disease: a new link between monoamine oxidase and mitochondrial electron flow. Proc. Natl Acad. Sci. USA 94, 48904894.DOI: 10.1073/pnas.94.10.4890
  • Da Costa C. A., Ancolio K. & Checler F. (2000) Wild-type but not Parkinson's disease-related A53T mutant alpha-synuclein protects neuronal cells from apoptotic stimuli. J. Biol. Chem. 275, 2406524069.
  • El-Agnaf O. M. & Irvine G. B. (2000) Formation and properties of amyloid-like fibrils derived from alpha-synuclein and related proteins. J. Struct. Biol. 130, 300309.DOI: 10.1006/jsbi.2000.4262
  • Fenteany G. & Schreiber S. L. (1998) Lactacystin, proteasome function and cell fate. J. Biol. Chem. 273, 85458548.
  • Fujita-Yamaguchi Y. & Kathuria S. (1998) Characterization of receptor tyrosine-specific protein kinases by the use of inhibitors. Staurosporine is a 100 times more potent inhibitor of insulin receptor than IGF-I receptor. Biochem. Biophy. Res. Comm. 157, 955962.
  • Goedert M., Jakes R., Crowther R. A., Hasegawa M., Smith M. J. & Spillantini M. G. (1998) Intraneuronal filamentous tau protein and α-synuclein deposits in neurodegenerative disease. Biochem. Soc. Trans. 26, 464471.
  • Grune T., Reinheckel T., Joshi M. & Davies K. J. (1995) Proteolysis in cultured liver epithelial cells during oxidative stress: Role of the multicatalytic proteinase complex, proteasome. J. Biol. Chem. 270, 23442351.
  • Halliwell B. (1997) What nitrates tyrosine? FEBS Lett. 411, 157160.DOI: 10.1016/s0014-5793(97)00469-9
  • Halliwell B. & Jenner P. (1998) Impaired clearance of oxidised proteins in neurodegenerative diseases. Lancet 351, 1510.
  • Harlow E. & Lane D. (1988). Antibodies: a Laboratory Manual. 2nd edn, Cold Spring Harbor Laboratory, Cold Spring Harbor.
  • Hashimoto M., Hsu L. J., Xia Y., Takeda A., Sisk A., Sundsmo M. & Masliah E. (1999a) Oxidative stress induces amyloid-like aggregate formation of NCAP/α-synuclein in vitro. Neuroreport 10, 717721.
  • Hashimoto M., Takeda A., Hsu L. J., Takenouchi T. & Masliah E. (1999b) Role of cytochrome c as a stimulator of α-synuclein aggregation in Lewy body disease. J. Biol. Chem. 274, 2884928852.
  • Hissin P. J. & Hilf R. (1976) A flourometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 74, 214226.
  • Jakes R., Spillantini M. G. & Goedert M. (1994) Identification of two distinct synucleins from human brain. FEBS Lett. 345, 2732.
  • Jenner P. & Olanow C. W. (1998) Understanding cell death in Parkinson's disease. Ann. Neurol. 44, S72S84.
  • Kaur H. & Halliwell B. (1996) Measurement of oxidized and methylated DNA bases by HPLC with electrochemical detection. Biochem. J. 318, 2123.
  • Khan J., Brennand D. M., Bradley N., Gao B., Bruckdorfer R. & Jacobs M. (1998) 3-Nitrotyrosine in the proteins of human plasma determined by an ELISA method. Biochem. J. 332, 807808.
  • Kholodilov N. G., Oo T. F. & Burke R. E. (1999) α-synuclein expression is decreased in rat substantia nigra following induction of apoptosis by intrastriatal 6-hydroxydopamine. Neurosci Lett. 275, 105108.DOI: 10.1016/s0304-3940(99)00740-5
  • Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Przuntek H., Epplen J. T., Schols L. & Riess O. (1998) Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nature Genet. 18, 106108.
  • Liu Y., Peterson D. A., Kimura H. & Schubert D. (1997) Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J. Neurochem. 69, 581593.
  • Lowry O. H., Rosebrough N. J., Farr A. L. & Randall R. J. (1951) Protein measurement with folin-phenol reagent. J. Biol. Chem. 193, 269275.
  • Lyras L., Evans P. J., Shaw P. J., Ince P. G. & Halliwell B. (1996) Oxidative damage and motor neuron disease: difficulties in the measurement of protein carbonyls in human brain tissue. Free Radic. Res. 24, 397406.
  • Lyras L., Cairns N. J., Jenner A., Jenner P. & Halliwell B. (1997) An assessment of oxidative damage to proteins, lipids and DNA in brain from patients with Alzheimer's disease. J. Neurochem. 68, 20612069.
  • Lyras L., Perry R. H., Perry E. K., Ince P. G., Jenner A., Jenner P. & Halliwell B. (1998) Oxidative damage to proteins, lipids, and DNA in cortical brain regions from patients with dementia with Lewy bodies. J. Neurochem. 71, 302312.
  • Maroteaux L., Campanelli J. T. & Scheller R. H. (1988) Synuclein, a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J. Neurosci. 8, 28042815.
  • Masliah E., Rockenstein E., Veinbergs I., Mallory M., Hashimoto M., Takeda A., Sagara Y., Sisk A. & Mucke L. (2000) Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287, 12651269.DOI: 10.1126/science.287.5456.1265
  • Mattila P. M., Rinne J. O., Helenius H., Dickson D. W. & Roytta M. (2000) Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease. Acta Neuropathol. 100, 285290.
  • McLord M., Stein M. & Beach D. (1987) The product of mei3+ gene, expressed under control of the mating type locus, induces meiosis and sporulation in fission yeast. EMBO J. 6, 729736.
  • Mezey E., Dehejia A., Harta G., Papp M. I., Polymeropoulos M. H. & Brownstein M. J. (1998) Alpha-synuclein in neurodegenerative disorders, murderer or accomplice? Nature Med. 4, 755759.
  • Oliver C. N., Starke-Reed P. E., Stadtman E. R., Liu G. J., Carney J. M. & Floyd R. A. (1990) Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain. Proc. Natl Acad. Sci. USA 87, 51445147.
  • Ostrerova-Golts N., Petrucelli L., Hardy J., Lee J. M., Farer M. & Wolozin B. (2000) The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity. J. Neurosci. 20, 60486054.
  • Polymeropoulos M. H., Lavedan C., Leroy E., Ide S. E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E. S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W. G., Lazzarini A. M., Duvoisin R. C., Di Iorio G., Golbe L. I. & Nussbaum R. L. (1997) Mutation in the α-synuclein identified in families with Parkinson's disease. Science 276, 20452047.DOI: 10.1126/science.276.5321.2045
  • Reznick A. Z. & Packer L. (1994) Oxidative damage to proteins, spectrophotometric methods for carbonyl assay. Methods Enzymol. 223, 357363.
  • Saha A. R., Ninkina N. N., Hanger D. P., Anderton B. H., Davies A. M. & Buchman V. L. (2000) Induction of neuronal death by alpha-synuclein. Eur. J. Neurosci. 12, 30733077.DOI: 10.1046/j.1460-9568.2000.00210.x
  • Sambrook J., Fritsch E. F. & Maniatis T. (1989). Molecular Cloning: a Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
  • Schapira A. H. V. (1999) Mitochondrial in the aetiology and pathogenesis of Parkinson's disease. Parkinsonism Related Disorders 5, 139143.DOI: 10.1016/s1353-8020(99)00029-2
  • Sian J., Dexter D. T., Lees A. J., Daniel S., Agid Y., Javoy-Agid F., Jenner P. & Marsden C. D. (1994) Glutathione-related enzymes in brain in Parkinson's disease. Ann. Neurol. 36, 5666.
  • Singer T. P., Castagnoli N. Jr, Ramsey R. R. & Trevor A. J. (1987) Biochemical events in the development of parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J. Neurochem. 49, 18.
  • Sitte N., Merker K. & Grune T. (1998) Proteasome-dependent degradation of oxidized proteins in MRC-5 fibroblasts. FEBS Lett. 44, 399402.
  • Spillantini M. G., Crowther R. A., Jakes R., Cairns N. J., Lantos P. L. & Goedert M. (1998a) Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci. Lett. 251, 205208.DOI: 10.1016/s0304-3940(98)00504-7
  • Spillantini M. G., Crowther R. A., Jakes R., Hasekawa M. & Goedert M. (1998b) α-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc. Natl Acad. Sci. USA 95, 64696473.DOI: 10.1073/pnas.95.11.6469
  • Stefani L., Burke R. E. & Greene L. A. (1997) Apoptosis in neurodegenerative disorders. Curr. Opin. Neurol. 10, 299305.
  • Van der Putten H., Wiederhold K. H., Probst A., Barbieri S., Mistl C., Danner S., Kauffmann S., Hofele K., Spooren W. P., Ruegg M. A., Lin S., Caroni P., Sommer B., Tolnay M. & Bilbe G. (2000) Neuropathology in mice expressing human alpha-synuclein. J. Neurosci. 20, 60216029.
  • Whiteman M. & Halliwell B. (1999) Loss of 3-nitrotyrosine on exposure to hypochlorous acid: implications for the use of 3-nitrotyrosine as a biomarker in vivo. Biochem. Biophys. Res. Com. 258, 168172.
  • Yermilov V., Rubio J. & Ohshima H. (1995) Formation of 8-nitroguanine in DNA treated with peroxynitrite in vitro and its rapid removal from DNA by depurination. FEBS Lett. 376, 207210.DOI: 10.1016/0014-5793(95)01281-6
  • Yoritaka A., Hattori N., Uchida K., Tanaka M., Stadtman E. R. & Mizuno Y. (1996) Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc. Natl Acad. Sci. USA 93, 26962701.DOI: 10.1073/pnas.93.7.2696
  • Zhou W., Hurlbert M. S., Schaack J., Prasad K. N. & Freed C. R. (2000) Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells. Brain Res. 866, 3343.DOI: 10.1016/s0006-8993(00)02215-0